Aronora
Privately held: no public share price
Assets
(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
AB002No recent activity | Phase 2 | Protein CProtein / enzyme therapeutic | Chronic Kidney Disease |
| Phase 2 | Factor XIMonoclonal antibody | Chronic Kidney Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.